Somatic dysfunction during carisoprodol cessation: Evidence for a carisoprodol withdrawal syndrome

Journal of the American Osteopathic Association

Volumn 103, Issue 2, 2003, Pages 75-80

  Reeves, Roy R ^a,c   Parker, Jefferson D ^b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Addiction; Carisoprodol; Meprobamate; Somatic dysfunction; Withdrawal

Indexed keywords

CARISOPRODOL;

ADULT; ANALYSIS OF VARIANCE; ANXIETY DISORDER; ARTICLE; BACKACHE; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG DEPENDENCE; DRUG MISUSE; DRUG URINE LEVEL; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; MALE; PHYSICAL EXAMINATION; WITHDRAWAL SYNDROME;

ADULT; CARISOPRODOL; FEMALE; HUMANS; MALE; MUSCLE RELAXANTS, CENTRAL; SOMATOSENSORY DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0037331289     PISSN: 00986151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Littrell RA, Hayes RA, Stillner V. Carisoprodol (Soma): A new and cautious perspective on an old agent. South Med J. 1993;86:753-756.
2. Douglas JF, Ludwig GJ, Schlosser A. The metabolic fate of carisoprodol in the dog. J Pharmacol Exp Ther. 1982;138:21-27.
3. Meyer MC, Straughn A. Meprobamate. J Am Pharm Assoc. 1977;17:173-175.
4. Elder NC. Abuse of skeletal muscle relaxants. Am Fam Physician. 1991;44: 1223-1226.
5. Littrell RA, Sage T, Miller W. Meprobamate dependence secondary to carisprodol (Soma) use. Am J Drug Alcohol Abuse. 1993;19:133-134.
6. Rust GS, Hatch R, Gums JG. Carisoprodol as a drug of abuse. Arch Fam Med. 1993;2:429-332.
7. Sidkar S, Basu D, Malhotra AK, Varma VK, Mattoo SK. Carisoprodol abuse: a report from India. Acta Psychiatr Scand. 1993;88:302-303.
8. Luehr JG, Meyerle KA, Larson EW. Mail order (veterinary) drug dependence [letter]. JAMA. 1990;263:657.
9. Reeves RR, Pinkofsky HB, Carter OS. Carisoprodol: A drug of continuing abuse. J Am Osteopathic Assoc. 1997;97:723-724.
10. Morse RM, Chua L. Carisoprodol dependence: A case report. Am J Drug Alcohol Abuse. 1978;5:527-530.
11. Reeves RR, Carter OS, Pinkofsky HB. Use of carisoprodol by substance abusers to modify the effects of illicit drugs [letter]. South Med J. 1999;92:441.
12. Davis GD, Alexander CB. A review of carisoprodol deaths in Jefferson County, Alabama. South Med J. 1998;91:726-730.
13. Lemere F. Habit forming properties of meprobamate (Miltown or Equanil). Arch Neurol Psychiat. 1956;76:205.
14. Essig CF, Ainslie JD. Addiction to meprobamate (Equanil, Miltown) [letter]. JAMA. 1957;164:1382.
15. Ewing JA, Fullilove RE. Addiction to meprobamate. N Engl J Med. 1957; 257:76-77.
16. Haizlip TM, Ewing JA. Meprobamate habituation, a controlled study. N Engl J Med. 1958;258:1181-1186.
17. Bulla JD, Ewing JA, Buffaloe WJ. Further controlled studies of meprobamate. American Practitioner and Digest of Treatment. 1959;10:1961-1964.
18. Boyd LG, Cammer L, Mulinos MG, Huppert VF, Hammer H. Meprobamate addiction. JAMA. 1958;168:1839-1843.
19. Physicians Desk Reference. 55th ed. Montvale, NJ: Medical Economics Co; 2001: pp 3252-3253.
20. Wyller TB, Korsmo G, Gadeholt G. Dependence on carisoprodol (Somadril)?. A prospective study among prisoners (Norwegian). Tidsskrifft Den Norske Laegeforening. 1991;111:193-195.
21. Greenman PE. Principles of Manual Medicine. Baltimore, Md: Williams & Wilkins; 1989; pp 127-134, 151-153, 205-206.
22. SPSS 10.0 for Windows. Chicago, III: SPSS Inc; 1999.
23. Munro BH. Statistical Methods for Health Care Research. 3rd ed. Philadelphia, Pa: Lippincott; 1997.
24. Reeves RR, Carter OS, Struve FA, Pinkofsky HB, Bennett DM. Carisoprodol (soma): Abuse potential and physician unawareness. J Addict Dis. 1999;18(2):51-56.